An open-label, long term follow-up study with Keppra XR [levetiracetam] for treatment of partial-onset seizures.

Trial Profile

An open-label, long term follow-up study with Keppra XR [levetiracetam] for treatment of partial-onset seizures.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Oct 2016

At a glance

  • Drugs Levetiracetam (Primary)
  • Indications Partial epilepsies
  • Focus Adverse reactions
  • Sponsors UCB
  • Most Recent Events

    • 13 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 22 Sep 2009 Planned number of patients changed from 220 to 190 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top